Literature DB >> 26856743

Haematological cancer: MRD assessment - guiding decisions for patients with AML.

Diana Romero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26856743     DOI： 10.1038/nrclinonc.2016.16

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Assessment of Minimal Residual Disease in Standard-Risk AML.

Authors:  Adam Ivey; Robert K Hills; Michael A Simpson; Jelena V Jovanovic; Amanda Gilkes; Angela Grech; Yashma Patel; Neesa Bhudia; Hassan Farah; Joanne Mason; Kerry Wall; Susanna Akiki; Michael Griffiths; Ellen Solomon; Frank McCaughan; David C Linch; Rosemary E Gale; Paresh Vyas; Sylvie D Freeman; Nigel Russell; Alan K Burnett; David Grimwade
Journal:  N Engl J Med       Date:  2016-01-20       Impact factor: 91.245
  1 in total
  3 in total

1.  Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia: a Danish population-based study.

Authors:  Andreas K Øvlisen; Anders Oest; Mette D Bendtsen; John Bæch; Preben Johansen; Line S Lynggaard; Ingolf Mølle; Thomas B Mortensen; Duruta Weber; Gideon Ertner; Claudia Schöllkopf; Jesper Q Thomassen; Ove Juul Nielsen; Lene Sofie Granfeldt Østgård; Martin Bøgsted; Karen Dybkær; Hans E Johnsen; Marianne T Severinsen
Journal:  Blood Adv       Date:  2018-03-13

2.  Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid Leukemia.

Authors:  Azza M Kamel; Nahla M Elsharkawy; Eman Z Kandeel; Marwa Hanafi; Mohammed Samra; Randa A Osman
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

Review 3.  Trisomy 21 with t(5; 11) chromosomal translocation as new unfavorable cytogenetic abnormalities in pediatric acute myeloid leukemia type M2: One case report of nine-year follow-up and literature review.

Authors:  Lin Wang; Xiao-Yan Wu; Run-Ming Jin; Bing-Yu Zhang; Yi-Ning Qiu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.